403
Sorry!!
Error! We're sorry, but the page you were
looking for doesn't exist.
Oncolytics Biotech Inc.
(MENAFN- Baystreet) 10:34 AM EST - Oncolytics Biotech Inc. : Today reported on highlights and financial results for Q4 and year-end 2024. The net loss for the fourth quarter of 2024 was $8.0 million, compared to a net loss of $3.9 million for the fourth quarter of 2023. The basic and diluted loss per share was $0.10 in the fourth quarter of 2024, compared to a basic and diluted loss per share of $0.05 in the fourth quarter of 2023.
Oncolytics Biotech Inc. shares T are trading down $0.10 at $0.98.
Oncolytics Biotech Inc. shares T are trading down $0.10 at $0.98.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
Comments
No comment